What did Nova Leap Health Corp. pay for South Central U.S. HHA (Texas)?

Nova Leap Health Corp. acquired South Central U.S. HHA (Texas) for $1.6M in 2021 (5.1x EBITDA), equivalent to 0.50x revenue. Target revenue was approximately $3.4M. Target EBITDA was approximately $0.3M.

What does South Central U.S. HHA (Texas) do?

South Central U.S. HHA (Texas) is a home health business.

What multiple did Nova Leap Health Corp. pay for South Central U.S. HHA (Texas)?

5.1x EBITDA and 0.50x revenue, based on disclosed deal value of $1.6M and disclosed financials.

M&A TRANSACTION · 2021

South Central U.S. HHA (Texas) acquired by Nova Leap Health Corp.

$1.6M· 5.1x EBITDA· 0.50x revenue

Target

South Central U.S. HHA (Texas)

Acquirer

Nova Leap Health Corp.

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$3.4M

EBITDA

$0.3M

Deal Value

$1.6M

EV/EBITDA

5.1x

Context

This $1.6M acquisition of South Central U.S. HHA (Texas) by Nova Leap Health Corp. sits in the home health sub-vertical. The 5.1x EBITDA multiple paid in 2021 can be compared against the population median for home health transactions of similar size on our Home Health valuation hub. Nova Leap Health Corp. is acquiring as a strategic buyer; see how strategic acquirers typically price home health businesses on our Home Health strategic buyer-pool page.

Source

Data sourced from Financial statements and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own home health

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the South Central U.S. HHA (Texas) acquisition.

Citation: ExitValue.ai. (2021). South Central U.S. HHA (Texas) acquired by Nova Leap Health Corp.. https://exitvalue.ai/deals/south-central-us-hha-texas-acquired-by-nova-leap-health-corp-hc-2021-0083